The Molecular Diagnostics Laboratory is responsible for the development and performance of molecular diagnostic tests for nucleic acid targets found in a variety of settings in medicine. We offer a ...

Point of Care Testing and Molecular Diagnostics are converging to streamline frontline testing, reduce costs and expand infectious disease testing into offices and homes.Dublin, Oct. (GLOBE NEWSWIRE) ...

IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...

Initiative integrates Aranscia's 2bPrecise and Spesana platforms with leading molecular laboratories to streamline genomic testing across Northside's cancer care network Historically, disparate ...

SEATTLE — Molecular testing has been widely integrated into mainstream healthcare, and its use is increasing in dermatology. It can help differentiate between skin conditions, for example, as some ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Syndromic multiplex diagnostics can lower costs, improve outcomes and combat Anti Microbial Resistance as Point of Care Testing and Molecular Diagnostics converge.Dublin, Oct. (GLOBE NEWSWIRE) -- ...

(Nasdaq: CNSY) (“Cerenome” or the “Company ”), today announced the commercial launch of two new cerebrospinal fluid (CSF)-based molecular profiling tests, available to health care professionals in the ...

SALT LAKE CITY, Sept. 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of ...

Earnings Call Insights: Insight Molecular Diagnostics Inc. (IMDX) Q3 2025 Management reiterated its plan to submit for FDA authorization of GraftAssureDx by year-end and is targeting a mid-2026 ...